Glycan-Modified Cellular Nanosponges for Enhanced Treatment of Cholera Toxin-Induced Secretory Diarrhea
Journal of the American Chemical Society · 21.05.2025 · 147 (20) · 16982-16991
DOI: 10.1021/jacs.5c00955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 09.05.2025. Verfasst von Tianzhen Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China. Hauptthemen laut MEDLINE: Cholera Toxin, Polysaccharides, Diarrhea, Nanostructures. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
Cholera is a severe infectious disease caused by the Gram-negative bacterium Vibrio cholerae after colonization in the intestinal tract. Cholera toxin (CT), a key exotoxin protein, primarily causes acute secretory diarrhea and life-threatening complications in infected patients. Traditional approaches remain insufficient for effectively treating cholera, underscoring the need for innovative countermeasures to eliminate CT-caused symptoms. Here, we report a glycan-modified cellular nanosponge for the enhanced treatment of CT-induced secretory diarrhea. Specifically, intestinal epithelial cell membrane-camouflaged nanosponges are functionalized with a glycan receptor to promote their capability for CT neutralization, thereby competitively inhibiting CT entry into host cells. Moreover, an inhibitor is encapsulated into the cellular nanosponge to synergistically improve the therapeutic effect of diarrhea by blocking the excessive chloride ion efflux from the cystic fibrosis transmembrane conductance regulator (a crucial anion channel) on the membrane of CT-intoxicated epithelial cells. Upon oral administration, the biomimetic nanomedicine effectively eliminates CT-induced secretory diarrhea and intestinal injuries in mice. Overall, this study highlights the potential of glycan-modified cellular nanosponges as promising and broad-spectrum therapeutic agents against secretory diarrhea caused by bacterial exotoxins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
- State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, Chi…
- Institute of Key Raw Material, Shanghai Academy of Experimental Medicine, Shanghai 201401, China.
ORCID-Profile: Guangyu Yang, Xiangzhao Ai
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
Zitieren
APA
Han, T., Zhu, W., Xu, R., Chiang, S. T., Jin, X., Shen, X., Qian, C., Yang, G., Li, R., & Ai, X. (2025). Glycan-Modified Cellular Nanosponges for Enhanced Treatment of Cholera Toxin-Induced Secretory Diarrhea. Journal of the American Chemical Society, 147(20), 16982-16991. https://doi.org/10.1021/jacs.5c00955
Vancouver
Han T, Zhu W, Xu R, Chiang ST, Jin X, Shen X, et al. Glycan-Modified Cellular Nanosponges for Enhanced Treatment of Cholera Toxin-Induced Secretory Diarrhea. Journal of the American Chemical Society. 2025;147(20):16982-16991. doi:10.1021/jacs.5c00955
BibTeX
@article{Han2025,
author = {Han, Tianzhen and Zhu, Wangyang and Xu, Rong and Chiang, Seok Theng and Jin, Xuefeng and Shen, Xiaoshuai and Qian, Chunxi and Yang, Guangyu and Li, Rongxiu and Ai, Xiangzhao},
title = {Glycan-Modified Cellular Nanosponges for Enhanced Treatment of Cholera Toxin-Induced Secretory Diarrhea},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {20},
pages = {16982--16991},
doi = {10.1021/jacs.5c00955}
}
EUVIMED